Literature DB >> 28835483

Targeting von Willebrand Factor-Mediated Inflammation.

Clive Drakeford1, James S O'Donnell2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28835483     DOI： 10.1161/ATVBAHA.117.309817

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  6 in total

1.  Functional regulation of von Willebrand factor ameliorates acute ischemia-reperfusion kidney injury in mice.

Authors:  Shiro Ono; Hideto Matsui; Masashi Noda; Shogo Kasuda; Noritaka Yada; Kiyomi Yoshimoto; Masashi Akiyama; Toshiyuki Miyata; Mitsuhiko Sugimoto; Kenji Nishio
Journal:  Sci Rep       Date:  2019-10-08       Impact factor: 4.379

Review 2.  New Drug Targets to Prevent Death Due to Stroke: A Review Based on Results of Protein-Protein Interaction Network, Enrichment, and Annotation Analyses.

Authors:  Michael Maes; Nikita G Nikiforov; Kitiporn Plaimas; Apichat Suratanee; Daniela Frizon Alfieri; Edna Maria Vissoci Reiche
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

3.  The von Willebrand factor - ADAMTS-13 axis in malaria.

Authors:  Andrew S O'Donnell; Judicael Fazavana; James S O'Donnell
Journal:  Res Pract Thromb Haemost       Date:  2022-02-01

4.  Associations between inflammation, coagulation, cardiac strain and injury, and subclinical vascular disease with frailty in older men: a cross-sectional study.

Authors:  Douglas G J McKechnie; Meera Patel; A Olia Papacosta; Lucy T Lennon; Elizabeth A Ellins; Julian P J Halcox; Sheena E Ramsay; Peter H Whincup; S Goya Wannamethee
Journal:  BMC Geriatr       Date:  2022-05-09       Impact factor: 4.070

5.  Molecular Framework of Mouse Endothelial Cell Dysfunction during Inflammation: A Proteomics Approach.

Authors:  Michael T Rossi; Jordan C Langston; Narender Singh; Carmen Merali; Qingliang Yang; Salim Merali; Balabhaskar Prabhakarpandian; Laurie E Kilpatrick; Mohammad F Kiani
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

Review 6.  Full-length recombinant antibodies from Escherichia coli: production, characterization, effector function (Fc) engineering, and clinical evaluation.

Authors:  Md Harunur Rashid
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.